Protheragen, an ISO9001 certified supplier of pharmaceutical ingredients, has unveiled its comprehensive lineup of high-quality pharmaceutical excipient products.
NEW YORK, NY, May 21, 2026 /24-7PressRelease/ — Protheragen, an ISO9001 certified supplier of pharmaceutical ingredients, has unveiled its comprehensive lineup of high-quality pharmaceutical excipient products, including specialized sustained & controlled release materials, diversified cellulose series products, and transdermal drug delivery systems materials, catering to the evolving demands of modern pharmaceutical formulation development and drug delivery innovation across the industry.
Pharmaceutical excipients serve as indispensable non-active ingredients in pharmaceutical manufacturing, underpinning drug stability, solubility, release regulation, safety, and overall efficacy. Beyond shaping the appearance, color, and flavor of dosage forms, these excipients perform core functional roles including binders to maintain tablet integrity, diluents for standardized size and weight, disintegrants to facilitate API release in the stomach, lubricants to optimize processing and swallowing, flavoring agents for palatability, and preservatives to extend shelf life. Protheragen’s full range of pharmaceutical excipients adheres to stringent industry quality benchmarks, with every batch undergoing rigorous purity testing, regulatory compliance verification, and systematic retesting for warehoused inventory, ensuring consistent quality and reliable performance for pharmaceutical production.
Central to Protheragen’s pharmaceutical excipient products are professional sustained & controlled release materials, which are pivotal components in sophisticated drug delivery systems. Differentiated by release patterns, sustained-release materials enable slow, non-constant drug release while controlled-release materials deliver steady, constant drug output, both cutting down dosing frequency, stabilizing blood drug concentration and significantly boosting patient compliance. Protheragen categorizes these materials into polymers, lipid-based materials, and inorganic materials. Polymeric options such as HPMC, ethyl cellulose, and PLGA support diffusion-controlled, matrix and reservoir delivery systems; lipid-based carriers like liposomes and lipid nanoparticles enhance solubility and targeted delivery for lipophilic drugs; inorganic materials including mesoporous silica and hydroxyapatite feature high surface area for adjustable API adsorption and release. These materials are widely applied in oral, transdermal and injectable drug delivery systems, covering chronic disease management, pain relief, hormone therapy and contraception.
Protheragen’s cellulose series excipients stand out as a foundational product line derived from naturally sourced cellulose via physical and chemical modification. The portfolio encompasses microcrystalline cellulose and powdered cellulose with superior compressibility for direct compression, cellulose ethers such as HPMC, EC and CMC-Na serving as binders, thickeners and coating agents, functional derivatives including L-HPC and HPMCAS as super disintegrants and enteric coating materials, as well as co-processed composite cellulose excipients with synergistic multi-functional properties. Widely used in solid, liquid and advanced drug delivery formulations, the cellulose series addresses key industry challenges such as solubilizing poorly soluble drugs, streamlining production processes, and achieving precise site-specific drug release.
Beyond core product lines, Protheragen also provides specialized materials for transdermal drug delivery systems, including pressure-sensitive adhesives, polymer matrices, permeation enhancers and backing films. These materials enable stable transdermal drug absorption, bypass gastrointestinal and liver metabolism, maintain long-term therapeutic blood concentration, and reduce individual absorption differences.
As the pharmaceutical industry advances toward precision and long-acting formulations, Protheragen continues to leverage its robust product matrix and strict quality control to supply compliant, high-performance materials, driving the development of safer, more effective and patient-centric pharmaceutical products worldwide.
About Protheragen
Protheragen is a leading global chemical supplier specializing in the research, development and supply of high-quality APIs, pharmaceutical excipients, intermediates, cosmetic ingredients and additives, solvents, and many other chemicals. With a focus on quality, innovation, safety and environmental responsibility, Protheragen serves a diverse range of industries including pharmaceuticals, agriculture, manufacturing, electronics, and academic research, providing tailored chemical solutions that drive efficiency, sustainability, and progress worldwide.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer: This article was provided by an independent third-party content provider. Kyrion Media makes no warranties or representations in connection with it. All information is provided “as is” without warranty of any kind. This content may not have been reviewed by our editorial staff and is published automatically. The views expressed in this article are those of the author and do not necessarily reflect the views of Kyrion Media. All trademarks are the property of their respective owners. If you are affiliated with this article and would like it removed, please contact retract@kyrionmedia.com.
